BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Greene CJ, Sharma NJ, Fiorica PN, Forrester E, Smith GJ, Gross KW, Kauffman EC. Suppressive effects of iron chelation in clear cell renal cell carcinoma and their dependency on VHL inactivation. Free Radical Biology and Medicine 2019;133:295-309. [DOI: 10.1016/j.freeradbiomed.2018.12.013] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Selka A, Doiron JA, Lyons P, Dastous S, Chiasson A, Cormier M, Turcotte S, Surette ME, Touaibia M. Discovery of a novel 2,5-dihydroxycinnamic acid-based 5-lipoxygenase inhibitor that induces apoptosis and may impair autophagic flux in RCC4 renal cancer cells. European Journal of Medicinal Chemistry 2019;179:347-57. [DOI: 10.1016/j.ejmech.2019.06.060] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
2 Harigae H, Hino K, Toyokuni S. Iron as Soul of Life on Earth Revisited: From Chemical Reaction, Ferroptosis to Therapeutics. Free Radical Biology and Medicine 2019;133:1-2. [DOI: 10.1016/j.freeradbiomed.2019.01.042] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
3 Greene CJ, Attwood K, Sharma NJ, Balderman B, Deng R, Muhitch JB, Smith GJ, Gross KW, Xu B, Kauffman EC. Iron accumulation typifies renal cell carcinoma tumorigenesis but abates with pathological progression, sarcomatoid dedifferentiation, and metastasis. Front Oncol 2022;12:923043. [DOI: 10.3389/fonc.2022.923043] [Reference Citation Analysis]
4 Hui Y, Tang T, Wang J, Zhao H, Yang HY, Xi J, Zhang B, Fang J, Gao K, Wu Y. Fusaricide is a Novel Iron Chelator that Induces Apoptosis through Activating Caspase-3. J Nat Prod 2021;84:2094-103. [PMID: 34292737 DOI: 10.1021/acs.jnatprod.0c01322] [Reference Citation Analysis]
5 Chen YY, Hu HH, Wang YN, Liu JR, Liu HJ, Liu JL, Zhao YY. Metabolomics in renal cell carcinoma: From biomarker identification to pathomechanism insights. Arch Biochem Biophys 2020;695:108623. [PMID: 33039388 DOI: 10.1016/j.abb.2020.108623] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Mou Y, Zhang Y, Wu J, Hu B, Zhang C, Duan C, Li B. The Landscape of Iron Metabolism-Related and Methylated Genes in the Prognosis Prediction of Clear Cell Renal Cell Carcinoma. Front Oncol 2020;10:788. [PMID: 32528886 DOI: 10.3389/fonc.2020.00788] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
7 DeRosa A, Leftin A. The Iron Curtain: Macrophages at the Interface of Systemic and Microenvironmental Iron Metabolism and Immune Response in Cancer. Front Immunol 2021;12:614294. [PMID: 33986740 DOI: 10.3389/fimmu.2021.614294] [Reference Citation Analysis]
8 Lai Y, Tang F, Huang Y, He C, Chen C, Zhao J, Wu W, He Z. The tumour microenvironment and metabolism in renal cell carcinoma targeted or immune therapy. J Cell Physiol 2021;236:1616-27. [PMID: 32783202 DOI: 10.1002/jcp.29969] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]